Medical devices and pharma from LATAM and Africa to the $4.5T US market

The healthcare and life sciences sector represents one of the most dynamic and high-growth corridors in US–Latin America–Africa trade. With aging populations, rising chronic disease burdens, and accelerating digital health adoption, demand for medical devices, pharmaceuticals, diagnostics, and biotech solutions has never been greater. Latin America and Africa are emerging as both significant suppliers of raw materials and essential intermediates, and as rapidly expanding markets for US exports.

For US buyers, sourcing from these regions offers cost advantages, supply chain diversification, and access to unique natural products. For suppliers in Latin America and Africa, the US market presents a $4.5 trillion healthcare ecosystem with stringent quality requirements but substantial rewards. This page provides a comprehensive overview of trade opportunities, regulatory pathways, and how to navigate this complex vertical.

Exporting Healthcare & Life Sciences to the US

Latin America and Africa supply a wide range of healthcare and life sciences products to the US market. Key product categories include surgical instruments and medical devices (such as gloves, syringes, and diagnostic kits), active pharmaceutical ingredients (APIs), botanical extracts for nutraceuticals, and biological materials for research. Mexico is the largest Latin American exporter of medical devices to the US, with over $18 billion in shipments in 2022, driven by its proximity and integration into US supply chains (USITC Dataweb 2023).

Brazil and Colombia are significant suppliers of pharmaceutical intermediates and generic drugs, while India and South Africa lead in Africa for API production and specialty generics. US buyers include hospital group purchasing organizations (GPOs), pharmaceutical manufacturers, clinical research organizations, and medical device distributors. The US FDA regulates all medical products, requiring rigorous premarket approvals, quality system regulations (QSR), and good manufacturing practices (GMP).

Suppliers must demonstrate compliance with US Pharmacopeia (USP) standards for pharmaceuticals and ISO 13485 for medical devices. The US market also offers preferential duty treatment under the African Growth and Opportunity Act (AGOA) for eligible sub-Saharan African countries, reducing tariffs on certain medical products.

Importing Healthcare & Life Sciences from the US

US exporters find strong demand in Latin America and Africa for advanced medical technologies, specialty pharmaceuticals, diagnostic equipment, and vaccines. Latin America accounts for approximately 10% of global pharmaceutical sales, with Brazil, Mexico, and Argentina leading imports of US biologics and oncology drugs (IQVIA 2023). In Africa, the pharmaceutical market is projected to reach $70 billion by 2030, driven by rising healthcare investment and local manufacturing gaps (McKinsey & Company 2022).

US medical device exports to Africa grew 12% annually from 2018 to 2022, with South Africa, Nigeria, and Kenya as primary destinations (USITC Dataweb 2023). Key use cases include hospital infrastructure projects, telemedicine deployments, and chronic disease management programs. However, importers must navigate varying regulatory frameworks: Latin American countries often require local registration and compliance with regional standards like Mercosur’s GMP guidelines, while African nations increasingly harmonize under the African Medicines Agency (AMA).

US exporters benefit from free trade agreements with Mexico and Colombia, reducing tariffs on medical devices and pharmaceuticals.

Regulatory and Compliance Overview

Regulatory compliance is the single most critical factor in healthcare and life sciences trade. In the US, the FDA enforces rigorous standards for medical devices (21 CFR 800-1299), drugs (21 CFR 200-299), and biologics (42 CFR 73). Foreign suppliers must register their establishments, list their products, and comply with current Good Manufacturing Practices (cGMP).

For medical devices, a 510(k) premarket notification or Premarket Approval (PMA) is typically required, depending on risk classification. Latin American regulators, such as COFEPRIS in Mexico, ANVISA in Brazil, and INVIMA in Colombia, have their own registration processes that can take 6–24 months. In Africa, the African Medicines Agency (AMA) is working toward harmonization, but currently each country has its own national regulatory authority, such as SAHPRA in South Africa and NAFDAC in Nigeria.

Key compliance areas include labeling in Spanish or Portuguese for Latin America, serialization requirements for pharmaceuticals, and adherence to ISO standards. Intellectual property protection is also vital; suppliers should secure patents and trademarks in target markets. Coppermont advises clients on regulatory mapping, dossier preparation, and liaison with regulatory bodies to streamline market entry.

Countries and Trade Corridors

Active trade corridors in healthcare and life sciences span multiple regions. From Latin America to the US: Mexico leads in medical devices and surgical instruments, followed by Costa Rica for cardiovascular devices and Puerto Rico for pharmaceuticals. Colombia exports generic drugs and botanical extracts; Brazil supplies vaccines and biologics.

From Africa to the US: South Africa exports pharmaceutical intermediates and medical gloves; Kenya supplies surgical instruments and diagnostic kits; Ghana and Nigeria offer nutraceuticals and herbal medicines. In the reverse direction, US exports flow heavily to Brazil (oncology drugs, diagnostic imaging), Mexico (hospital equipment, vaccines), Colombia (medical devices), South Africa (biologics, dental supplies), and Nigeria (antiretrovirals, vaccines). Emerging corridors include US–Chile for telemedicine technology and US–Rwanda for digital health platforms.

Each corridor has unique logistical, regulatory, and cultural dynamics that require specialized knowledge.

How Coppermont Advisory Works for This Vertical

Coppermont provides end-to-end trade advisory for healthcare and life sciences, from supplier identification to regulatory compliance and market entry strategy. For US buyers, we conduct rigorous due diligence on Latin American and African suppliers, verifying FDA registrations, quality certifications, and production capacity. We facilitate sample testing, negotiate contracts, and manage logistics including cold chain shipping for temperature-sensitive biologics.

For suppliers, we develop US market entry plans, prepare regulatory submissions, identify distribution partners, and advise on pricing and reimbursement strategies. Our team includes former regulatory affairs professionals, supply chain experts, and trade finance specialists who understand the nuances of this vertical. We have successfully assisted clients in sectors including medical devices, pharmaceuticals, nutraceuticals, and diagnostics, reducing time-to-market by an average of 40%.

Whether you are a US hospital group seeking cost-effective surgical gloves from Mexico or a Colombian API manufacturer entering the US market, we tailor our approach to your specific needs.